• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Clinical trials roundup: Medtronic, St. Jude, Covidien tout studies

Clinical trials roundup: Medtronic, St. Jude, Covidien tout studies

November 20, 2010 By MassDevice staff

Clinical trials roundup

A trio of big-name medical device makers are touting the results of clinical trials for several products designed to monitor or treat atrial fibrillation, stroke, thoracic and abdominal aortic aneurysms and unexplained fainting.

Minneapolis-based Medtronic Inc. (NYSE:MDT) led the way with a trio of studies. The company released one-year and 30-day data, respectively, for two of the trials: An investigational device exemption look at Medtronic’s Endurant stent graft in treating AAA and an IDE study of the Valiant graft for TAA. The third study looked at the company’s Reveal line of insertable cardiac monitors led in diagnosing and treating unexplained fainting.

Not to be outdone by its Twin Cities peer, St. Jude Medical Inc. (NYSE:STJ) announced results from its Assert study, saying it showed that monitoring implants can help predict stroke.

And Covidien plc (NYSE:COV) produced evidence it said showed the clinical effectiveness of its VNUS ClosureFast catheter, which it acquired for $440 million last year.

Here’s a roundup of other recent clinical trial news:

  • Study: Fish oil capsules don’t help atrial fibrillation
    Prescription supplements of omega-3 fatty acids do not appear to prevent recurrences of atrial fibrillation, a type of irregular heartbeat that can lead to stroke, researchers report, according to WebMD.
    Read more
  • Kidney procedure reduces high blood pressure, study finds
    A simple surgical procedure destroying certain nerves in the kidney can sharply reduce blood pressure in patients whose hypertension cannot be controlled with conventional medications, researchers said Wednesday, the Los Angeles Times reported.
    Read more
  • Tengion advances clinical trial for Neo-Urinary Conduit in bladder cancer patients
    Tengion Inc. (NSDQ:TNGN) announced that the scheduled one-month, post-operative clinical assessment of the first implanted bladder cancer patient in its ongoing clinical trial has been completed as expected and has permitted the second patient to be enrolled without delay.
    Read more
  • Medical Acoustics wins research grant for Lung Flute clinical trial
    Medical Acoustics LLC announced that it has been awarded a UB CAT/NYSTAR grant. The $75,000 grant, awarded by the University at Buffalo Center for Advanced Biomedical and Bioengineering Technology, is funded by the New York State Foundation for Science Technology and Innovation (NYSTAR) and will help finance a clinical trial entitled, “Six Month Clinical Trial of Lung Flute in Patients with COPD.” The total cost of the study is expected to be approximately $250,000.
    Read more
  • OptiMedica’s Catalys Precision Laser System Study Published in Science Translational Medicine Shows Marked Advancement in Cataract Surgery
    OptiMedica Corp. announced that results from a clinical study of its Catalys precision laser system were published in the peer-reviewed journal Science Translational Medicine (“Femtosecond Laser-Assisted Cataract Surgery with Integrated Optical Coherence Tomography,” Volume 2, Issue 58, November 17, 2010). The data showed that, when compared to manual techniques, the Catalys system helped surgeons achieve significant improvement in precision during several critical steps of cataract surgery.
    Read more
  • ArterX clinical trial results announced at Veith meeting
    U.S. clinical trial results for Tenaxis’ investigational vascular surgical sealant, ArterX, were presented today at the Veith Meeting in New York. Dr. William Stone of the Mayo Clinic reported a more than 20 percent margin of improvement for ArterX Surgical Sealant in the sealing of vascular suture lines compared with a control group featuring a commercially available gelatin foam/thrombin combination.
    Read more
  • NIH-Funded study is first to demonstrate increased long-term survival with favorable neurologic function among patients receiving CPR using ACSI ResQPump and ResQPOD CPR devices
    A combination of two devices could save the lives of several thousand cardiac arrest patients each year if implemented nationwide, suggests results of a clinical trial presented at the American Heart Assn.’s Resuscitation Science Symposium.
    Read more
  • Cardio3 BioSciences announces positive outcome of the C-Cure Phase II clinical trial in heart failure patients
    Cardio3 BioSciences announced positive six-month results, including significant functional and clinical benefit, from the Phase II clinical trial of its development programme C-Cure, designed as a novel stem cell therapy for heart failure based on breakthrough technology.
    Read more
  • Alliance Surgical Distributors unveils utilization study
    Alliance Surgical Distributors conducted a study of its flagship distributorship, Inland Spine and Orthopedics, finding that surgical case volumes following inception of the distributorship were consistent with years prior to formation of the distributorship and varied only with volume of new patient visits.
    Read more
  • New findings show bioequivalence, ease-of-use and efficiency of MannKind’s drug delivery platform
    MannKind Corp. (NSDQ:MNKD) unveiled new data on its drug delivery, device and particle technologies demonstrating the bioequivalence, ease of use and efficiency of its novel platform.
    Read more
  • Catheter ablation improves atrial fibrillation symptoms and quality of life compared with drug therapy
    According to data appearing today in Circulation Cardiovascular Quality and Outcomes, patients with atrial fibrillation treated with catheter ablation using the Navistar ThermoCool catheter reported markedly fewer symptoms and substantially improved quality of life than patients treated with antiarrhythmia drugs at one year.
    Read more
  • Ardian’s catheter-based hypertension treatment lowers blood pressure
    Late-breaking data presented at the American Heart Assn. Scientific Sessions 2010 and simultaneously published in The Lancet demonstrated that the landmark Symplicity HTN-2 trial evaluating Ardian’s Symplicity catheter system met its primary endpoint.
    Read more

Filed Under: Business/Financial News, News Well Tagged With: Clinical Trials, Covidien, stjudemedical

In case you missed it

  • Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
  • FDA says Philips ventilator recall produced over 21,000 device reports, 124 deaths
  • Boston Scientific’s Acurate Neo2 valve performs well in studies
  • MicroTransponder reports first commercial implantation of its stroke rehab neurostim system
  • Ambu replaces CEO with new leadership
  • Moderna’s first bivalent COVID-19 vaccine booster candidate shows promise
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
  • FDA clears Accelus’ Toro-L interbody fusion system
  • Teleflex’s UroLift cleared in China to treat BPH
  • Globus Medical announces first surgeries with Excelsius3D
  • Abbott reports positive data on heart valve therapies
  • OncoRes Medical raises another $12.5M
  • NeuroMetrix’s Quell neuromodulation device wins FDA de novo nod to treat fibromyalgia
  • Inogen appoints Agnes Lee as senior VP of investor relations, strategic planning
  • Google Health hires FDA’s chief digital health officer
  • ApiJect picks up $111M investment from Royalty Pharma, Jefferies
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says

RSS From Medical Design & Outsourcing

  • Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
    An unusually large share of Zimmer Biomet (NYSE:ZBH) investors voted against the orthopedics company’s pay packages for top executives at the annual shareholder meeting. About 54% of voting shareholders supported the pay packages of the company’s five top-paid executives at the May 13 meeting, according to results filed with the SEC yesterday. In 2021, nearly 93%… […]
  • BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
    BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD and Tokyo-based MGC will work together to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for advanced… […]
  • Ambu replaces CEO with new leadership
    Ambu today said it has hired board member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez, effective tomorrow. “Since Juan Jose Gonzalez joined as CEO in 2019, Ambu has made good progress and achieved important milestones on the strategic transformation into the world’s largest single-use endoscopy company,” Ambu Chair Jørgen Jensen said in a… […]
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
    AdvaMed executive Abby Pratt has joined the executive committee for the Biden administration’s Joint Supply Chain Resilience Working Group, the medtech industry association said today. The working group’s members from government and industry will assist with implementation of the National Strategy for a Resilient Public Health Supply Chain. Pratt oversees supply chain issues as SVP… […]
  • Toray develops new stretchable film for medical devices
    Toray Industries has a new stretchable film based on its proprietary polymer Reactis technology, with potential applications that include robotics and biological and industrial sensors. Tokyo-based Toray said it shipped samples to customers and plans research and development efforts to commercialize the new grade of film. “Recent years have increased the potential for developing stretchable… […]
  • Google Health hires FDA’s chief digital health officer
    Former FDA Chief Digital Health Officer of Global Strategy and Innovation Bakul Patel has started a new job with Google after 13 years with the regulatory agency. Patel became senior director, global digital health strategy and regulatory for Google Health earlier this month, he said on LinkedIn. Patel recounted highlights of his “incredible journey since… […]
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
    Two years into the COVID-19 pandemic, we know more than ever about the SARS-CoV-2 virus and how quickly it moves to ravage the human body. What remains to be seen is how the virus — and perhaps more importantly, our immune system’s response to it — will affect the health of people long after infection,… […]
  • FDA moves forward with Voluntary Improvement Program to bolster medical device quality
    Kathryn Burke, Emergo Group The U.S. Food and Drug Administration has issued new draft guidance to establish a full-blown voluntary program for improving quality-related processes in medical device manufacturing following promising results of a pilot program. The FDA guidance stems from a pilot undertaken by the agency along with the Medical Device Innovation Consortium (MDIC) in 2018.… […]
  • How Minnetronix Medical helped Lazurite with its wireless surgical camera
    Minnetronix Medical (St. Paul, Minnesota) has played an important development and manufacturing partner role with Lazurite’s wireless surgical camera system. It’s been nearly two months since Lazurite (formerly Indago) announced FDA 510(k) clearance of its ArthroFree system. ArthroFree combines proprietary low-heat, high-intensity Meridiem light engine technology with advanced camera, battery and wireless transmission technologies and… […]
  • Instron releases TrendTracker data analysis workflow platform
    Instron announced that it released the TrendTracker module in Bluehill Central for accelerating data analysis workflows. Norwood, Massachusetts-based Instron designed TrendTracker with an intuitive interface to improve the data analysis workflow of single or multi-location materials testing laboratories. According to a news release, the platform features quick searching and the ability to display and analyze… […]
  • Henry Schein hires former Medline veteran to drive ‘One Distribution’ push
    Henry Schein (Nasdaq:HSIC) today named Dirk Benson as VP and chief commercial officer of the medical device manufacturer and distributor’s North America Distribution Group (NADG). Melville, New York-based Henry Schein is the world’s largest provider of health care supplies and services for office-based dental and medical practitioners, and NADG is the company’s largest business group. The… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS